Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
Zuqin Rao1,2, Heng Li3, Wenchao Yao1,2
1Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Insights
Decaprenyl diphosphate synthase subunit 1 (PDSS1) is upregulated in hepatocellular carcinoma (HCC), correlating with poor prognosis and increased immune cell infiltration. PDSS1 knockdown inhibits HCC cell proliferation, migration, and invasion, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Decaprenyl diphosphate synthase subunit 1 (PDSS1) is implicated in human diseases, but its role in hepatocellular carcinoma (HCC) remains uncharacterized.
- Understanding PDSS1's function in HCC is crucial for identifying novel biomarkers and therapeutic strategies.
Purpose of the Study:
- To investigate the expression pattern, biological function, and prognostic significance of PDSS1 in HCC.
- To explore the relationship between PDSS1 and immune infiltration in the HCC microenvironment.
Main Methods:
- Analysis of PDSS1 expression using TCGA and GEO databases.
- Correlation analysis of PDSS1 with clinicopathological characteristics and patient survival.
- Gene Set Enrichment Analysis (GSEA) and assessment of immune cell infiltration using GSVA.
- In vitro functional assays (EdU, colony formation, Transwell, wound healing, flow cytometry) to evaluate PDSS1's impact on HCC cell phenotype.
- Investigation of PDSS1's role in oncogenic pathways, including STAT3 signaling.
Main Results:
- PDSS1 was significantly upregulated in HCC tissues compared to adjacent non-tumorous tissues.
- High PDSS1 expression correlated with unfavorable overall survival, disease-specific survival, and progression-free interval in HCC patients.
- PDSS1 knockdown suppressed HCC cell proliferation, cell cycle progression, migration, and invasion, indicating its oncogenic role.
- PDSS1 expression was associated with various immune cells, including Th2, TFH, T helper cells, NK cells, cytotoxic cells, dendritic cells, CD8 T cells, and neutrophils.
- PDSS1 promotes tumorigenesis in HCC, potentially through the STAT3 signaling pathway.
Conclusions:
- Elevated PDSS1 levels in HCC are linked to poor patient prognosis and altered immune cell infiltration.
- PDSS1 functions as an oncogene in HCC, impacting cell proliferation, cycle, and invasion.
- PDSS1 represents a promising novel biomarker and potential therapeutic target for hepatocellular carcinoma.
Abstract:
Decaprenyl diphosphate synthase subunit 1 (PDSS1) is closely related to a variety of human diseases, but its expression pattern and biological function in HCC have not been studied to date.
Methods:
The expression level of PDSS1 was analyzed using the TCGA and GEO databases. The relationships between PDSS1 and patient clinicopathological characteristics were verified based on TCGA clinical data. Additionally, the co-expressed genes of PDSS1were investigated and Gene Set Enrichment Analysis (GSEA) was conducted using LinkedOmics. Next, the association between PDSS1 and immune infiltration was determined using version 1.34.0 of the GSVA package. EdU assay, colony-formation assay, transwell assay, wound-healing assay, and flow cytometry analysis were used to assess the effect of PDSS1 on the cell phenotype.
Results:
PDSS1 was upregulated in HCC compared with adjacent tissues. High PDSS1 in HCC was associated with poor overall survival, disease-specific survival, and progress-free interval. Results suggested that PDSS1 may activate multiple oncogenic pathways in HCC, especially those involved in the cell cycle. The expression of PDSS1 was significantly related to Th2 cells, TFH, T helper cells, NK CD56bright cells, cytotoxic cells, DC, CD8 T cells, and neutrophils. PDSS1 knockdown inhibited cell proliferation, cell cycle, migration and invasion. Furthermore, PDSS1 acted as an oncogene through the STAT3 signaling pathway.
Conclusion:
Our study reveals that a high level of PDSS1 is significantly correlated with poor patient prognosis and immune cell infiltration in HCC. PDSS1 may be a novel biomarker and potential therapeutic target for HCC.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Hedgehog Signaling Pathway

